Neural basis of major depressive disorder: Beyond monoamine hypothesis
…, S Nakagawa, H Toda, A Hishimoto - Psychiatry and clinical …, 2018 - Wiley Online Library
The monoamine hypothesis has been accepted as the most common hypothesis of major
depressive disorder (MDD) for a long period because of its simplicity and understandability. …
depressive disorder (MDD) for a long period because of its simplicity and understandability. …
[HTML][HTML] Current status of neurofeedback for post-traumatic stress disorder: a systematic review and the possibility of decoded neurofeedback
…, S Boku, A Hishimoto… - Frontiers in human …, 2019 - frontiersin.org
Background: Post-traumatic stress disorder (PTSD) is a neuropsychiatric affective disorder
that can develop after traumatic life-events. Exposure-based therapy is currently one of the …
that can develop after traumatic life-events. Exposure-based therapy is currently one of the …
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by …
Cannabinoids, endocannabinoids and marijuana activate two well‐characterized cannabinoid
receptors (CB‐Rs), CB1‐Rs and CB2‐Rs. The expression of CB1‐Rs in the brain and …
receptors (CB‐Rs), CB1‐Rs and CB2‐Rs. The expression of CB1‐Rs in the brain and …
[HTML][HTML] Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors
…, S Awasthi, M Gandal, JD Hafferty, A Hishimoto… - Biological …, 2022 - Elsevier
Background Suicide is a leading cause of death worldwide, and nonfatal suicide attempts,
which occur far more frequently, are a major source of disability and social and economic …
which occur far more frequently, are a major source of disability and social and economic …
GWAS meta-analysis of suicide attempt: identification of 12 genome-wide significant loci and implication of genetic risks for specific health factors
…, H Hakonarson, KA Halmi, A Hishimoto… - American journal of …, 2023 - Am Psychiatric Assoc
Objective: Suicidal behavior is heritable and is a major cause of death worldwide. Two large-scale
genome-wide association studies (GWASs) recently discovered and cross-validated …
genome-wide association studies (GWASs) recently discovered and cross-validated …
Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms
Neurexins are cell adhesion molecules that help to specify and stabilize synapses and provide
receptors for neuroligins, neurexophilins, dystroglycans and α-latrotoxins. We previously …
receptors for neuroligins, neurexophilins, dystroglycans and α-latrotoxins. We previously …
Association of FKBP5 gene haplotypes with completed suicide in the Japanese population
…, Y Ueno, Y Nagasaki, O Shirakawa, A Hishimoto - Progress in neuro …, 2011 - Elsevier
BACKGROUND: The hypothalamus–pituitary–adrenal (HPA) axis is known to have a role in
suicidal behaviors in patients with affective disorders. However, the incomplete overlapping …
suicidal behaviors in patients with affective disorders. However, the incomplete overlapping …
Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation
…, M Fuchikami, S Okada, S Boku, A Hishimoto… - Epigenetics, 2015 - Taylor & Francis
Aberrant DNA methylation in the blood of patients with major depressive disorder (MDD)
has been reported in several previous studies. However, no comprehensive studies using …
has been reported in several previous studies. However, no comprehensive studies using …
Identification of novel, replicable genetic risk loci for suicidal thoughts and behaviors among US military veterans
…, H Hakonarson, KA Halmi, A Hishimoto… - JAMA …, 2023 - jamanetwork.com
Importance Suicide is a leading cause of death; however, the molecular genetic basis of
suicidal thoughts and behaviors (SITB) remains unknown. Objective To identify novel, replicable …
suicidal thoughts and behaviors (SITB) remains unknown. Objective To identify novel, replicable …
[HTML][HTML] Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of …
N Hashimoto, N Yasui-Furukori, N Hasegawa… - Asian Journal of …, 2021 - Elsevier
Background Monopharmacy with antipsychotics and antidepressants is the first-line treatment
for schizophrenia and major depressive disorder (MDD) in most clinical guidelines, while …
for schizophrenia and major depressive disorder (MDD) in most clinical guidelines, while …